Cargando…
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013
A systematic review was performed to evaluate how the maximum recommended starting dose (MRSD) was determined in first-in-human (FIH) studies with monoclonal antibodies (mAbs). Factors associated with the choice of each MRSD determination method were also identified. PubMed was searched for FIH stud...
Autores principales: | Suh, Hoon Young, Peck, Carl C, Yu, Kyung-Sang, Lee, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153257/ https://www.ncbi.nlm.nih.gov/pubmed/27994442 http://dx.doi.org/10.2147/DDDT.S121520 |
Ejemplares similares
-
Recently published papers: The message is clear – start early?
por: Spivey, Mike, et al.
Publicado: (2004) -
An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review
por: Simeone, Jason C., et al.
Publicado: (2015) -
Boronic acids for sensing and other applications - a mini-review of papers published in 2013
por: Lacina, Karel, et al.
Publicado: (2014) -
Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017) -
Global Research on Cognitive Frailty: A Bibliometric and Visual Analysis of Papers Published during 2013–2021
por: Hui, Zhaozhao, et al.
Publicado: (2022)